Small-molecule RORγt antagonists inhibit T helper 17 cell transcriptional network by divergent mechanisms.
暂无分享,去创建一个
Mark S. Sundrud | A. Regev | R. Young | N. Yosef | D. Hafler | A. Marson | Chuan Wu | V. Kuchroo | P. Rahl | S. Xiao | Jianfei Yang | Yonghui Wang | Ling Zhou | Chen Zhu | E. Baloglu | Darby R Schmidt | R. Ramesh | M. Lobera | Pei-Yun Tsai | Zhijun Xiang | Jinsong Wang | Yan Xu | Xichen Lin | K. Kretschmer | Zhong Zhong | S. Ghosh | Karsten Kretschmer | R. Young | R. Young
[1] R. Sharan,et al. Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells. , 2003, Genome research.
[2] J. Barrett,et al. New IBD genetics: common pathways with other diseases , 2011, Gut.
[3] M. Genovese,et al. LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study. , 2010, Arthritis and rheumatism.
[4] Judy H. Cho,et al. Effector CD4+ T Cell Expression Signatures and Immune-Mediated Disease Associated Genes , 2012, PloS one.
[5] Graham M Lord,et al. The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genes , 2009, Proceedings of the National Academy of Sciences.
[6] Retinoic Acid Increases Foxp3+ Regulatory T Cells and Inhibits Development of Th17 Cells by Enhancing TGF-β-Driven Smad3 Signaling and Inhibiting IL-6 and IL-23 Receptor Expression1 , 2008, The Journal of Immunology.
[7] Pui-Yan Kwok,et al. Genomewide Scan Reveals Association of Psoriasis with IL-23 and NF-κB Pathways , 2008, Nature Genetics.
[8] Raja Jothi,et al. Genome-wide analyses of transcription factor GATA3-mediated gene regulation in distinct T cell types. , 2011, Immunity.
[9] A. Regev,et al. Dynamic regulatory network controlling Th17 cell differentiation , 2013, Nature.
[10] Clifford A. Meyer,et al. Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.
[11] William Stafford Noble,et al. Quantifying similarity between motifs , 2007, Genome Biology.
[12] Marc Vandemeulebroecke,et al. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial , 2012, Gut.
[13] S. Rutz,et al. A Genomic Regulatory Element That Directs Assembly and Function of Immune-Specific AP-1–IRF Complexes , 2012, Science.
[14] W. Ouwehand,et al. Combinatorial transcriptional control in blood stem/progenitor cells: genome-wide analysis of ten major transcriptional regulators. , 2010, Cell stem cell.
[15] D. Patel,et al. Effect of IL-17A blockade with secukinumab in autoimmune diseases , 2012, Annals of the rheumatic diseases.
[16] J. Rinn,et al. Ab initio reconstruction of transcriptomes of pluripotent and lineage committed cells reveals gene structures of thousands of lincRNAs , 2010, Nature Biotechnology.
[17] Richard Bonneau,et al. A Validated Regulatory Network for Th17 Cell Specification , 2012, Cell.
[18] Ernest Fraenkel,et al. Foxp3 occupancy and regulation of key target genes during T-cell stimulation , 2007, Nature.
[19] D. Koller,et al. The Immunological Genome Project: networks of gene expression in immune cells , 2008, Nature Immunology.
[20] J. Ortonne,et al. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. , 2012, The New England journal of medicine.
[21] R. Shamir,et al. Transcription factor and microRNA motif discovery: the Amadeus platform and a compendium of metazoan target sets. , 2008, Genome research.
[22] T. Mcclanahan,et al. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17–producing effector T helper cells in vivo , 2009, Nature Immunology.
[23] H. Weiner,et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.
[24] Michael M. Ward,et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci , 2010, Nature Genetics.
[25] B. Lim,et al. Retinoic Acid Increases Foxp3+ Regulatory T Cells and Inhibits Development of Th17 Cells by Enhancing TGF-β-Driven Smad3 Signaling and Inhibiting IL-6 and IL-23 Receptor Expression1 , 2008, The Journal of Immunology.
[26] A. Regev,et al. Induction and molecular signature of pathogenic T[subscript H]17 cells , 2012 .
[27] Michael Q. Zhang,et al. TRED: a transcriptional regulatory element database, new entries and other development , 2007, Nucleic Acids Res..
[28] Lior Pachter,et al. Sequence Analysis , 2020, Definitions.
[29] Thomas Korn,et al. IL-17 and Th17 Cells. , 2009, Annual review of immunology.
[30] Yuelei Shen,et al. TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function , 2008, Nature.
[31] S. Batzoglou,et al. Genome-Wide Analysis of Transcription Factor Binding Sites Based on ChIP-Seq Data , 2008, Nature Methods.
[32] T. Mcclanahan,et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation , 2005, The Journal of experimental medicine.
[33] Subhashis Banerjee,et al. Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. , 2012, The New England journal of medicine.
[34] Qing Yang,et al. ITFP: an integrated platform of mammalian transcription factors , 2008, Bioinform..
[35] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[36] J. O’Shea,et al. Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5 , 2011, Nature Immunology.
[37] Avi Ma'ayan,et al. ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments , 2010, Bioinform..
[38] Tatiana Tatusova,et al. NCBI Reference Sequence (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins , 2004, Nucleic Acids Res..
[39] Wilfred W. Li,et al. MEME: discovering and analyzing DNA and protein sequence motifs , 2006, Nucleic Acids Res..
[40] Dan R. Littman,et al. Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity , 2011, Nature.
[41] A. Rudensky,et al. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells , 2007, Nature.
[42] Pui-Yan Kwok,et al. Genome-wide scan reveals association of psoriasis with IL-23 and NFB pathways , 2016 .
[43] Judy H. Cho,et al. The genetics and immunopathogenesis of inflammatory bowel disease , 2008, Nature Reviews Immunology.
[44] D. Littman,et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. , 2006, Cell.
[45] S. Eyre,et al. Polymorphisms in the IL-12beta and IL-23R genes are associated with psoriasis of early onset in a UK cohort. , 2008, The Journal of investigative dermatology.
[46] D. Mennerich,et al. Next-generation insights into regulatory T cells: expression profiling and FoxP3 occupancy in Human , 2011, Nucleic acids research.
[47] J. Mesirov,et al. GenePattern 2.0 , 2006, Nature Genetics.
[48] Dušica Vidović,et al. Suppression of TH17 Differentiation and Autoimmunity by a Synthetic ROR Ligand , 2011, Nature.
[49] Yuka Kanno,et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. , 2009, Immunity.
[50] Cole Trapnell,et al. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.
[51] Mark S. Sundrud,et al. Pharmacologic Inhibition of RORγt Regulates Th17 Signature Gene Expression and Suppresses Cutaneous Inflammation In Vivo , 2014, The Journal of Immunology.
[52] Graham M. Lord,et al. T-bet and GATA3 orchestrate Th1 and Th2 differentiation through lineage-specific targeting of distal regulatory elements , 2012, Nature Communications.
[53] Helga Thorvaldsdóttir,et al. Molecular signatures database (MSigDB) 3.0 , 2011, Bioinform..